Tango Therapeutics Debuts as Publicly Traded Precision Oncology Company Focused on the Next Generation of Targeted Cancer Therapies
– Business combination transaction with BCTG Acquisition Corp., a special purpose acquisition company sponsored by Boxer Capital, completed today –
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of BCTG Acquisition Corp. Merger
WILMINGTON, Del., April 22, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating BCTG Acquisition Corp. (“BCTG”) (NASDAQ GS: BCTG ) regarding possible breaches of fiduciary...
Tango Therapeutics and BCTG Acquisition Corp. Announce Merger Agreement to Create Publicly Listed Precision Medicine Company Focused on the Next Generation of Targeted Cancer Therapies
Tango Therapeutics , a biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, and BCTG Acquisition Corp. (Nasdaq: BCTG), a special purpose acquisition...